A5053848713- Acute Myocardial Infarction Research
- Coronary Interventions and Diagnostics
- Cardiac Imaging and Diagnostics
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Arrest and Resuscitation
- Cardiac, Anesthesia and Surgical Outcomes
- Colorectal Cancer Surgical Treatments
- Peripheral Artery Disease Management
- Mechanical Circulatory Support Devices
- Diverticular Disease and Complications
- Vascular Procedures and Complications
- Venous Thromboembolism Diagnosis and Management
- Aortic aneurysm repair treatments
- Cerebrovascular and Carotid Artery Diseases
- Organ Donation and Transplantation
- Cardiac Arrhythmias and Treatments
- Gastrointestinal Tumor Research and Treatment
- Stoma care and complications
- Gastric Cancer Management and Outcomes
- Atrial Fibrillation Management and Outcomes
- Liver Disease and Transplantation
- Cancer Research and Treatments
- Eosinophilic Esophagitis
- Heart Failure Treatment and Management
- Helicobacter pylori-related gastroenterology studies
OLVG
2012-2024
University Medical Center Groningen
2024
Medisch Centrum Leeuwarden
2024
Amsterdam University Medical Centers
2021
Maastricht University
2020
Vitenparken
2017
Amsterdam University College
2017
Park University
2017
University of Amsterdam
1954-2011
Amsterdam UMC Location University of Amsterdam
2011
Ischemic heart disease is a major cause of out-of-hospital cardiac arrest. The role immediate coronary angiography and percutaneous intervention (PCI) in the treatment patients who have been successfully resuscitated after arrest absence ST-segment elevation myocardial infarction (STEMI) remains uncertain.
Journal Article Local recurrence of cancer in the large bowel: The role implantation metastases and bowel disinfection Get access M Vink University Amsterdam, Surgical Clinic, Wilhelmina Gasthuis Search for other works by this author on: Oxford Academic Google Scholar British Surgery, Volume 41, Issue 168, January 1954, Pages 431–433, https://doi.org/10.1002/bjs.18004116826 Published: 06 December 2005
<h3>Importance</h3> Ischemic heart disease is a common cause of cardiac arrest. However, randomized data on long-term clinical outcomes immediate coronary angiography and percutaneous intervention (PCI) in patients successfully resuscitated from arrest the absence ST segment elevation myocardial infarction (STEMI) are lacking. <h3>Objective</h3> To determine whether improves at 1 year after without signs STEMI, compared with delayed strategy. <h3>Design, Setting, Participants</h3> A...
<h3>Objective</h3> To examine the feasibility of a routine transradial approach (TRA) in primary percutaneous coronary intervention (PPCI) for acute ST-segment elevation myocardial infarction (STEMI). <h3>Design</h3> A single-centre observational study with prospective data collection. <h3>Setting</h3> high-volume interventional centre Amsterdam, The Netherlands. <h3>Patients</h3> Procedural were analysed 2209 consecutive patients presenting STEMI without cardiogenic shock, between January...
In primary percutaneous coronary intervention (PPCI), stenting has been shown to reduce the need for repeat target lesion revascularisation (TLR) compared balloon angioplasty alone, but did not result in a reduction of recurrent myocardial infarction (MI) or cardiac death. Meanwhile, stent-related adverse events such as stent thrombosis continue be concern. Our aim was evaluate safety and feasibility drug- coated (DCB) without PPCI.One hundred patients presenting with ST-elevation MI were...
The randomized REVELATION (REVascularization With PaclitaxEL-Coated Balloon Angioplasty Versus Drug-Eluting Stenting in Acute Myocardial InfarcTION) trial showed that the setting of ST-segment elevation myocardial infarction (STEMI), a drug-coated balloon (DCB) strategy was non-inferior to drug-eluting stent (DES) terms fractional flow reserve assessed at 9 months. aim present study is evaluate long-term clinical outcome this treatment strategy.
This follow-up study was performed to assess the long-term effects of paclitaxel-eluting stents (PES) compared with bare-metal (BMS) in patients who had undergone a percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI).The PASSION trial randomly assigned 619 STEMI receive either PES or BMS. The composite endpoint occurrence combination cardiac death, recurrent infarction, target lesion revascularisation (TLR) stent thrombosis at two years. A trend towards...
OBJECTIVES The randomized REVELATION (REVascularization With PaclitaxEL-Coated Balloon Angioplasty Versus Drug-Eluting Stenting in Acute Myocardial InfarcTION) trial showed that the setting of ST-segment elevation myocardial infarction (STEMI), a drug-coated balloon (DCB) strategy was non-inferior to drug-eluting stent (DES) terms fractional flow reserve assessed at 9 months. aim present study is evaluate long-term clinical outcome this treatment strategy. METHODS Between October 2014 and...
The objective of this study was to compare the efficacy and long-term clinical outcome manual thrombus aspiration with Export catheter (Medtronic, Minneapolis, MN) versus mechanical cutting/aspiration X-sizer system (eV3, White Bear Lake, in primary percutaneous coronary intervention (PPCI).In PPCI for acute ST-segment elevation myocardial infarction (STEMI), markers reperfusion are improved adjunctive thrombectomy. Previous studies different devices showed a variability performance,...
The OPTIMA trial was a randomised multicentre exploring the influence of timing percutaneous coronary intervention (PCI) on patient outcomes in an intermediate to high risk non-ST-elevation acute syndrome (NSTE-ACS) population. In order decide best treatment strategy for patients presenting with NSTE-ACS, long-term are essential.Five-year follow-up data from 133 142 could be retrieved (94 %). primary endpoint composite death and spontaneous myocardial infarction (MI). Spontaneous MI defined...
The optimal antithrombotic management of atrial fibrillation (AF) patients who require oral anticoagulation (OAC) undergoing percutaneous coronary intervention (PCI) remains unclear. Current guidelines recommend dual therapy (DAT; OAC plus P2Y
In primary percutaneous coronary intervention (PPCI) for ST-elevation myocardial infarction (STEMI), stenting has proved to reduce the need repeat revascularization compared with balloon angioplasty alone. The incidence of cardiac death or recurrent infarction, though, is not reduced by stenting. This in part attributable stent-related complications like stent thrombosis which may occur even years after implantation. A strategy drug coated (DCB) without would abolish potential disadvantages...